Sims Mark E. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Sims Mark E. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Mark E. Sims (also listed as Sims, Mark E.) is identified in SEC filings as an insider of Candel Therapeutics, Inc., with the most recent filing date provided as 2026-07-08. The current role (e.g., director, executive, or other insider) is not specified in the provided context. Candel Therapeutics is a biotechnology company focused on developing oncolytic viral therapies. Based on SEC disclosure, Mr. Sims is involved in ownership or insider activity requiring reporting to the SEC; however, publicly available biographical details beyond this context are not established in the provided data.
Role
Insider
Notability
40/100
Board memberships
Candel Therapeutics, Inc.
Awards & honors
Listed as an insider of Candel Therapeutics, Inc. in SEC filings as of 2026-07-08
Mark E. Sims (also listed as Sims, Mark E.) is identified in SEC filings as an insider of Candel Therapeutics, Inc., with the most recent filing date provided as 2026-07-08. The current role (e.g., director, executive, or other insider) is not specified in the provided context. Candel Therapeutics is a biotechnology company focused on developing oncolytic viral therapies. Based…
How many SEC Form 4 filings has Sims Mark E. submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Sims Mark E.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
